Industry sponsorship bias in cost effectiveness analysis: registry based analysis.
Feng XieTing ZhouPublished in: BMJ (Clinical research ed.) (2022)
Sponsorship bias in CEAs is significant, systemic, and present across a range of diseases and study designs. Use of CEAs conducted by independent bodies could provide payers with more ability to negotiate lower prices. This impartiality is especially important for countries that rely on published CEAs to inform policy making for insurance coverage because of limited capacity for independent economic analysis.